Patent · US Active

Pyrrolopyrimidine compounds and uses thereof

US10111875B2 · kind B2 · utility

1Cited by

0References

23Claims

0Family size

Assignee

HUTCHISON MEDIPHARMA LIMITED · CN

Inventors

Wei-Guo Su · Shanghai, CN
Wei Deng · Shanghai, CN
Jinshui Li · Shanghai, CN
Jianguo Ji · Shanghai, CN

Key dates

Filing date	Apr 20, 2016
Grant date	Oct 30, 2018
Priority date	—
Expiry date	Apr 20, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/07
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides pyrrolopyrimidine compounds and methods of use therefor. For example, the disclosure provides certain pyrrolopyrimidine compounds capable of inhibiting JAK kinases. The disclosure further provides the pharmaceutical compositions containing these pyrrolopyrimidine compounds, and use of these pyrrolopyrimidine compounds in the treatment of disorders or diseases, such as inflammatory diseases and cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.